Impact of glucagon‐like peptide‐1 receptor agonism‐based therapies on limb outcomes in peripheral artery disease and type 2 diabetes: An updated systematic review and meta‐analysis

Documenti analoghi

• The estrous cycle moderates the food and body weight suppressive effects of glucagon‐like peptide‐1 receptor agonism
  di: Sarah V. Applebey, et al.
  Pubblicazione: (2025)
• Impact of Real Time, Flash and Retrospective Continuous Glucose Monitoring on Feto‐Maternal Outcomes in Women With Gestational Diabetes and Pre‐Gestational Diabetes: A Systematic Review and Meta‐Analysis With Trial Sequential Analysis of Randomized Controlled Trials
  di: Deep Dutta, et al.
  Pubblicazione: (2026)
• Evaluating biased agonism of glucagon‐like peptide‐1 ( GLP ‐1) receptors to improve cellular bioenergetics: A systematic review
  di: Sabrina Wong, et al.
  Pubblicazione: (2025)
• Relative effects of genetically proxied glucagon‐like peptide‐1 receptor agonism on muscle and fat mass: A Mendelian randomization study
  di: Yiwen Liang, et al.
  Pubblicazione: (2025)
• Oppositely biased glucagon‐like peptide‐1 receptor agonism does not differentially affect lipid metabolism in APOE *3‐Leiden CETP mice
  di: Melanie Modder, et al.
  Pubblicazione: (2025)